Journal Mobile Options
Table of Contents
Vol. 214, No. 1, 2007
Issue release date: December 2006
Dermatology 2007;214:82–84
(DOI:10.1159/000096918)

Hemosiderotic Dermatofibroma: Report of One Case

Scalvenzi M. · Balato A. · De Natale F. · Francia M.G. · Mignogna C. · De Rosa G.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Dermatofibroma (DF) is a common benign fibrohistiocytic lesion which presents with a wide variety of clinicopathological features. Generally, the clinical diagnosis is easy, but differentiating it from other cutaneous tumors could be difficult in atypical cases and rare variants. We may find at least four different histopathological variants of DF; more than one of which may be present in a single tumor. Hemosiderotic DF is a variant composed of numerous small vessels, extravasated erythrocytes, and intra- and extracellular hemosiderotic deposits. The differential diagnosis may comprise melanoma as well as other melanocytic and nonmelanocytic tumors. We report the case of a 38-year-old man who presented with a hemosiderotic DF on the abdomen.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. From L, Assaad D: Neoplasms, pseudoneoplasms, and hyperplasias of the dermis; in Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick’s Dermatology in General Medicine, ed 5. New York, McGraw-Hill, 1999, vol 1, pp 1168–1169.
  2. Ferrari A, Soyer HP, Peris K, Argenziano G, Mazzocchetti G, Piccolo D, De Giorgi V, Chimenti S: Central white scarlike patch: a dermoscopic clue for the diagnosis of dermatofibroma. J Am Acad Dermatol 2000;43:1123–1125.
  3. Argenziano G, Soyer HP, Chimenti S, et al: Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003;48:679–693.
  4. Hairston MA Jr, Reed RJ: Aneurysmal sclerosing hemangioma of skin. Arch Dermatol 1966;93:439–442.
  5. Unna PG: Histopathologie der Hautkrankheiten. Berlin, Hirschwald, 1894, pp 839–842.
  6. Diss MA: Histiocytome hémosidérinique pseudomélanique de la peau. Bull Soc Fr Dermatol Syphiligr 1938;45:1903–1908.
  7. Zelger BG, Zelger B: Dermatofibroma. Ein klinisch-pathologisches Klassifikationsschema. Pathologe 1998;19:412–419.
  8. Santa Cruz DJ, Kyriakos M: Aneurysmal (‘angiomatoid’) fibrous histiocytoma of the skin. Cancer 1981;47:2053–2061.
  9. Zalaudek I, Argenziano G, Di Stefani A, Ferrara G, Marghoob AA, Hofmann-Wellenhof R, Soyer HP, Braun R, Kerl H: Dermoscopy in general dermatology. Dermatology 2006;212:7–18.
  10. Zaballos P, Llambrich A, Ara M, Olazaran Z, Malvehy J, Puig S: Dermoscopy findings of haemosiderotic and aneurysmal dermatofibroma: report of six patients. Br J Dermatol DOI: 10.1111/j.1365-2133.2005.06844.x
  11. Blum A, Jawovski S, Metzler G, Bauer J: Lessons on dermoscopy: dermoscopic pattern of hemosiderotic dermatofibroma. Dermatol Surg 2004;30:1354–1355.
  12. Carli P, Massi D, de Giorgi V, Giannotti B: Clinically and dermoscopically featureless melanoma: when prevention fails. J Am Acad Dermatol 2002;46:957–959.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00